DY268
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-110267-5MG | 5 mg | 140,00 | Add | |
| HY-110267-1ML | 10mM/1mL | 153,00 | Add | |
| HY-110267-10MG | 10 mg | 216,00 | Add | |
| HY-110267-50MG | 50 mg | 749,00 | Add | |
| HY-110267-100MG | 100 mg | 1'217,00 | Add | |
| HY-110267-S-1ST | Sample | Inquire |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
DY268 is a farnesoid X receptor (FXR) antagonist (IC50=7.5 nM). It inhibits FXR transactivation in a cell-based assay with an IC50 value of 468 nM. DY268 can be used in the study of drug-induced liver injury (DILI)[1][2].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Metabolic Enzyme/Protease |
| Format | Solubility: DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C) |
| Grade | Clinical information: No Development Reported |
| Purity | 99.32% |
| Molecular Formula | C30H32N4O5S |
| Molecular Weight | 560.66 |
| CAS-Number | 1609564-75-1 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
